Investor Presentation

IKS Health reported strong Q4 FY26 results with Revenue at ₹857.7 Cr (up 18.5% YoY) and PAT at ₹206 Cr (up 39.4% YoY). For the full year FY26, Revenue grew 19.9% YoY to ₹3,193.8 Cr, with PAT surging 48.4% YoY to ₹721.6 Cr.

This robust performance is underpinned by its comprehensive healthcare enablement platform, with over 90% of revenue from repeat customers.

The company is strategically advancing its AI-native platforms, having launched MyCareHub for patient engagement and an AI-driven Revenue Cycle Management engine achieving 95% coding accuracy.

Recent successes include a multi-year partnership with Holyoke Medical Center and an expanded RCM/Value-Based Care deal with a top 5 health system.

IKS Health is accelerating its AI strategy through proposed acquisitions of TruBridge, an EHR provider, and ARAI, an AI R&D firm.

This aims to create a unified 'Operating System for Healthcare,' integrating data from systems of record with AI-powered action platforms.

Management's FY2030 vision targets an EBITDA of ~₹3,000 Cr, showcasing confidence in its scalable platform and AI-first approach.